Shares of Johnson & Johnson (NYSE:JNJ) ended Monday session in green amid volatile trading. The shares closed up +0.68 points or 0.58% at $118.81 with 6.10 million shares getting traded. Post opening the session at $118.00, the shares hit an intraday low of $117.43 and an intraday high of $119.01 and the price vacillated in this range throughout the day. The company has a market cap of $327.43 billion and the numbers of outstanding shares have been calculated to be 2.74 billion shares.
Johnson & Johnson (JNJ) announced that it will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 18th, to review third-quarter results. Dominic Caruso, Executive Vice President, Chief Financial Officer, Joaquin Duato, Executive Vice President, Worldwide Chairman, Pharmaceuticals, Dr. William Hait, MD. PhD, Global Head Janssen Research & Development, LLC, and Joseph J. Wolk, Vice President, Investor Relations, will host the call.
Investors and other interested parties may access the conference call in the following ways:
The webcast is accessible at Johnson & Johnson’s website: www.investor.jnj.com. A webcast and podcast replay will be available approximately one hour after the conference call concludes.
By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.
A replay of the conference call will be available until approximately 12:00 a.m. on October 25, 2016. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13645877.
Presentation materials will be available on www.investor.jnj.com.
The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.
Shares of Celgene Corporation (NASDAQ:CELG) ended Monday session in red amid volatile trading. The shares closed down -0.26 points or -0.25% at $104.27 with 2.59 million shares getting traded. Post opening the session at $104.15, the shares hit an intraday low of $103.01 and an intraday high of $104.53 and the price vacillated in this range throughout the day. The company has a market cap of $82.21 billion and the numbers of outstanding shares have been calculated to be 775.11 million shares.
Celgene Corporation (CELG) announced that it will host a conference call and live audio webcast on Thursday, October 27, 2016 at 9 a.m. ET to discuss third quarter 2016 financial and operational results. The webcast can be accessed from the Investor Relations page at www.celgene.com.